Outpatient Facility Coding Alert - 2009 Issue 15
PHYSICIAN NOTES: Aberrant Claim Patterns for Inhalation Drugs in South Florida Set Off OIG's Radar
Subscribe or sign in to view the full article.
Article Overview
This piece covers an OIG report on unusual Medicare inhalation drug claim patterns in South Florida and briefly mentions CMS guidance related to e-prescribing claims. It is relevant to professionals tracking Medicare program integrity, DME-related billing oversight, and physician practice coding/compliance updates. The article focuses on broad oversight findings and the types of administrative actions CMS was urged to consider, rather than detailed coding instructions.
Why This Topic Matters
It highlights a federal program integrity review that may affect how claims are monitored and audited, especially for inhalation drugs and related supplier billing activity.
What You Will Learn
- What federal reviewers found about inhalation drug billing patterns in one geographic area
- How the article frames Medicare oversight concerns involving physician and supplier billing
- Why the article also points readers to CMS e-prescribing claim guidance
- What kinds of compliance and contractor-enforcement issues the article raises at a high level
Who Should Read This
- Physician practices
- Medical billers and coders
- Compliance staff
- DME suppliers
- Revenue cycle professionals
- Healthcare auditors
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com